| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911389 | Lung Cancer | 2011 | 7 Pages |
Abstract
Clinical efficacy of docetaxel was observed at all dose levels. Higher dose levels were not associated with increased toxicities, use of IV antibiotics or hospitalization rates. However, the median survival observed is shorter than historical data and do not support further evaluation of these doses of single agent docetaxel in this population.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Raffaele Califano, Richard Griffiths, Paul Lorigan, Linda Ashcroft, Paul Taylor, Paul Burt, Lip Lee, Abbas Chittalia, Margaret Harris, Corinne Faivre-Finn, Nick Thatcher, Fiona Blackhall,